Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the ... View Full Text


Ontology type: schema:ScholarlyArticle     


Article Info

DATE

2019-03-09

AUTHORS

F. Lynce, A. Barac, X. Geng, C. Dang, A. F. Yu, K. L. Smith, C. Gallagher, P. R. Pohlmann, R. Nunes, P. Herbolsheimer, R. Warren, M. B. Srichai, M. Hofmeyer, A. Cunningham, P. Timothee, F. M. Asch, A. Shajahan-Haq, M. T. Tan, C. Isaacs, S. M. Swain

ABSTRACT

PURPOSE: HER2-targeted therapies have substantially improved the outcome of patients with breast cancer, however, they can be associated with cardiac toxicity. Guidelines recommend holding HER2-targeted therapies until resolution of cardiac dysfunction. SAFE-HEaRt is the first trial that prospectively tests whether these therapies can be safely administered without interruptions in patients with cardiac dysfunction. METHODS: Patients with stage I-IV HER2-positive breast cancer candidates for trastuzumab, pertuzumab or ado-trastuzumab emtansine (TDM-1), with left ventricular ejection fraction (LVEF) 40-49% and no symptoms of heart failure (HF) were enrolled. All patients underwent cardiology visits, serial echocardiograms and received beta blockers and ACE inhibitors unless contraindicated. The primary endpoint was completion of the planned HER2-targeted therapies without developing either a cardiac event (CE) defined as HF, myocardial infarction, arrhythmia or cardiac death or significant asymptomatic worsening of LVEF. The study was considered successful if planned oncology therapy completion rate was at least 30%. RESULTS: Of 31 enrolled patients, 30 were evaluable. Fifteen patients were treated with trastuzumab, 14 with trastuzumab and pertuzumab, and 2 with TDM-1. Mean LVEF was 45% at baseline and 46% at the end of treatment. Twenty-seven patients (90%) completed the planned HER2-targeted therapies. Two patients experienced a CE and 1 had an asymptomatic worsening of LVEF to ≤ 35%. CONCLUSION: This study provides safety data of HER2-targeted therapies in patients with breast cancer and reduced LVEF while receiving cardioprotective medications and close cardiac monitoring. Our results demonstrate the importance of collaboration between cardiology and oncology providers to allow for delivery of optimal oncologic care to this unique population. More... »

PAGES

1-9

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s10549-019-05191-2

DOI

http://dx.doi.org/10.1007/s10549-019-05191-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1112673022

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/30852761


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1102", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Cardiorespiratory Medicine and Haematology", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Georgetown University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.411667.3", 
          "name": [
            "Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, 20057-1400, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lynce", 
        "givenName": "F.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MedStar Heart & Vascular Institute", 
          "id": "https://www.grid.ac/institutes/grid.489071.3", 
          "name": [
            "Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, 20057-1400, Washington, DC, USA", 
            "MedStar Heart & Vascular Institute, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Barac", 
        "givenName": "A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Georgetown University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.411667.3", 
          "name": [
            "Department of Biostatistics, Bioinformatics & Biomathematics, Georgetown University Medical Center, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Geng", 
        "givenName": "X.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Memorial Sloan Kettering Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Medicine, Weill Cornell Medical College, New York, NY, USA", 
            "Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dang", 
        "givenName": "C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Memorial Sloan Kettering Cancer Center", 
          "id": "https://www.grid.ac/institutes/grid.51462.34", 
          "name": [
            "Department of Medicine, Weill Cornell Medical College, New York, NY, USA", 
            "Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Yu", 
        "givenName": "A. F.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins Medicine", 
          "id": "https://www.grid.ac/institutes/grid.469474.c", 
          "name": [
            "The Johns Hopkins University School of Medicine, Baltimore, MD, USA", 
            "The Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Smith", 
        "givenName": "K. L.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MedStar Washington Hospital Center", 
          "id": "https://www.grid.ac/institutes/grid.415235.4", 
          "name": [
            "Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gallagher", 
        "givenName": "C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Georgetown University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.411667.3", 
          "name": [
            "Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, 20057-1400, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pohlmann", 
        "givenName": "P. R.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Johns Hopkins Medicine", 
          "id": "https://www.grid.ac/institutes/grid.469474.c", 
          "name": [
            "The Johns Hopkins University School of Medicine, Baltimore, MD, USA", 
            "The Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Nunes", 
        "givenName": "R.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AstraZeneca (United States)", 
          "id": "https://www.grid.ac/institutes/grid.418152.b", 
          "name": [
            "AstraZeneca, Gaithersburg, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Herbolsheimer", 
        "givenName": "P.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Georgetown University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.411667.3", 
          "name": [
            "Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, 20057-1400, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Warren", 
        "givenName": "R.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MedStar Georgetown University Hospital", 
          "id": "https://www.grid.ac/institutes/grid.411663.7", 
          "name": [
            "MedStar Heart & Vascular Institute, Washington, DC, USA", 
            "Department of Cardiology, MedStar Georgetown University Hospital, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Srichai", 
        "givenName": "M. B.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MedStar Heart & Vascular Institute", 
          "id": "https://www.grid.ac/institutes/grid.489071.3", 
          "name": [
            "MedStar Heart & Vascular Institute, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Hofmeyer", 
        "givenName": "M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MedStar Health", 
          "id": "https://www.grid.ac/institutes/grid.415232.3", 
          "name": [
            "MedStar Health Research Institute, Hyattsville, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Cunningham", 
        "givenName": "A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MedStar Health", 
          "id": "https://www.grid.ac/institutes/grid.415232.3", 
          "name": [
            "MedStar Health Research Institute, Hyattsville, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Timothee", 
        "givenName": "P.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "MedStar Health", 
          "id": "https://www.grid.ac/institutes/grid.415232.3", 
          "name": [
            "MedStar Heart & Vascular Institute, Washington, DC, USA", 
            "MedStar Health Research Institute, Hyattsville, MD, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Asch", 
        "givenName": "F. M.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Georgetown University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.411667.3", 
          "name": [
            "Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, 20057-1400, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Shajahan-Haq", 
        "givenName": "A.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Georgetown University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.411667.3", 
          "name": [
            "Department of Biostatistics, Bioinformatics & Biomathematics, Georgetown University Medical Center, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Tan", 
        "givenName": "M. T.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Georgetown University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.411667.3", 
          "name": [
            "Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, 20057-1400, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Isaacs", 
        "givenName": "C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Georgetown University Medical Center", 
          "id": "https://www.grid.ac/institutes/grid.411667.3", 
          "name": [
            "Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, 20057-1400, Washington, DC, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Swain", 
        "givenName": "S. M.", 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1200/jco.2011.40.0010", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1007962595"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.13.5467", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011604292"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa052306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014794593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa052306", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1014794593"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.02.4091", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024439769"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa0910383", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1028192490"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejm200103153441101", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1031768583"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.echo.2014.10.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035112289"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa052122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035589584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa052122", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1035589584"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2005.13.300", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036436122"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.echo.2009.05.020", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1039554114"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1209124", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1042743567"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1056/nejmoa1413513", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043562849"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3109/07357907.2014.922570", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1045073061"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/eurheartj/ehw022", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1047825539"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdt182", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1049729330"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2015-0125", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068164525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2015-0125", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1068164525"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2016.68.7830", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079360339"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2016.70.5400", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079363808"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2016-0412", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084355312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1634/theoncologist.2016-0412", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084355312"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jchf.2017.08.024", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1093117030"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1093/annonc/mdx773", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1099838694"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.echo.2017.11.018", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1100778508"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2019-03-09", 
    "datePublishedReg": "2019-03-09", 
    "description": "PURPOSE: HER2-targeted therapies have substantially improved the outcome of patients with breast cancer, however, they can be associated with cardiac toxicity. Guidelines recommend holding HER2-targeted therapies until resolution of cardiac dysfunction. SAFE-HEaRt is the first trial that prospectively tests whether these therapies can be safely administered without interruptions in patients with cardiac dysfunction.\nMETHODS: Patients with stage I-IV HER2-positive breast cancer candidates for trastuzumab, pertuzumab or ado-trastuzumab emtansine (TDM-1), with left ventricular ejection fraction (LVEF) 40-49% and no symptoms of heart failure (HF) were enrolled. All patients underwent cardiology visits, serial echocardiograms and received beta blockers and ACE inhibitors unless contraindicated. The primary endpoint was completion of the planned HER2-targeted therapies without developing either a cardiac event (CE) defined as HF, myocardial infarction, arrhythmia or cardiac death or significant asymptomatic worsening of LVEF. The\u00a0study was considered successful if planned oncology therapy completion rate was at least 30%.\nRESULTS: Of 31 enrolled patients, 30 were evaluable. Fifteen patients were treated with trastuzumab, 14 with trastuzumab and pertuzumab, and 2 with TDM-1. Mean LVEF was 45% at baseline and 46% at the end of treatment. Twenty-seven patients (90%) completed the planned HER2-targeted therapies. Two patients experienced a CE and 1 had an asymptomatic worsening of LVEF to \u2264 35%.\nCONCLUSION: This study provides safety data of HER2-targeted therapies in patients with breast cancer and reduced LVEF while receiving cardioprotective medications and close cardiac monitoring. Our results demonstrate the importance of collaboration between cardiology and oncology providers to allow for delivery of optimal oncologic care to this unique population.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1007/s10549-019-05191-2", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": false, 
    "isFundedItemOf": [
      {
        "id": "sg:grant.2438858", 
        "type": "MonetaryGrant"
      }
    ], 
    "isPartOf": [
      {
        "id": "sg:journal.1092777", 
        "issn": [
          "0167-6806", 
          "1573-7217"
        ], 
        "name": "Breast Cancer Research and Treatment", 
        "type": "Periodical"
      }
    ], 
    "name": "Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study", 
    "pagination": "1-9", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "951f32d31533c18dc08e82027476972daa2e49a051a1573f30c55b2b0bd095d7"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "30852761"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "8111104"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s10549-019-05191-2"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1112673022"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s10549-019-05191-2", 
      "https://app.dimensions.ai/details/publication/pub.1112673022"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T11:24", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000355_0000000355/records_53027_00000000.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1007%2Fs10549-019-05191-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s10549-019-05191-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s10549-019-05191-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s10549-019-05191-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s10549-019-05191-2'


 

This table displays all metadata directly associated to this object as RDF triples.

271 TRIPLES      21 PREDICATES      48 URIs      18 LITERALS      7 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s10549-019-05191-2 schema:about anzsrc-for:11
2 anzsrc-for:1102
3 schema:author N47e6e46d503e4b6bb4f47d30760854f3
4 schema:citation https://doi.org/10.1016/j.echo.2009.05.020
5 https://doi.org/10.1016/j.echo.2014.10.003
6 https://doi.org/10.1016/j.echo.2017.11.018
7 https://doi.org/10.1016/j.jchf.2017.08.024
8 https://doi.org/10.1056/nejm200103153441101
9 https://doi.org/10.1056/nejmoa052122
10 https://doi.org/10.1056/nejmoa052306
11 https://doi.org/10.1056/nejmoa0910383
12 https://doi.org/10.1056/nejmoa1209124
13 https://doi.org/10.1056/nejmoa1413513
14 https://doi.org/10.1093/annonc/mdt182
15 https://doi.org/10.1093/annonc/mdx773
16 https://doi.org/10.1093/eurheartj/ehw022
17 https://doi.org/10.1200/jco.2005.02.4091
18 https://doi.org/10.1200/jco.2005.13.300
19 https://doi.org/10.1200/jco.2007.13.5467
20 https://doi.org/10.1200/jco.2011.40.0010
21 https://doi.org/10.1200/jco.2016.68.7830
22 https://doi.org/10.1200/jco.2016.70.5400
23 https://doi.org/10.1634/theoncologist.2015-0125
24 https://doi.org/10.1634/theoncologist.2016-0412
25 https://doi.org/10.3109/07357907.2014.922570
26 schema:datePublished 2019-03-09
27 schema:datePublishedReg 2019-03-09
28 schema:description PURPOSE: HER2-targeted therapies have substantially improved the outcome of patients with breast cancer, however, they can be associated with cardiac toxicity. Guidelines recommend holding HER2-targeted therapies until resolution of cardiac dysfunction. SAFE-HEaRt is the first trial that prospectively tests whether these therapies can be safely administered without interruptions in patients with cardiac dysfunction. METHODS: Patients with stage I-IV HER2-positive breast cancer candidates for trastuzumab, pertuzumab or ado-trastuzumab emtansine (TDM-1), with left ventricular ejection fraction (LVEF) 40-49% and no symptoms of heart failure (HF) were enrolled. All patients underwent cardiology visits, serial echocardiograms and received beta blockers and ACE inhibitors unless contraindicated. The primary endpoint was completion of the planned HER2-targeted therapies without developing either a cardiac event (CE) defined as HF, myocardial infarction, arrhythmia or cardiac death or significant asymptomatic worsening of LVEF. The study was considered successful if planned oncology therapy completion rate was at least 30%. RESULTS: Of 31 enrolled patients, 30 were evaluable. Fifteen patients were treated with trastuzumab, 14 with trastuzumab and pertuzumab, and 2 with TDM-1. Mean LVEF was 45% at baseline and 46% at the end of treatment. Twenty-seven patients (90%) completed the planned HER2-targeted therapies. Two patients experienced a CE and 1 had an asymptomatic worsening of LVEF to ≤ 35%. CONCLUSION: This study provides safety data of HER2-targeted therapies in patients with breast cancer and reduced LVEF while receiving cardioprotective medications and close cardiac monitoring. Our results demonstrate the importance of collaboration between cardiology and oncology providers to allow for delivery of optimal oncologic care to this unique population.
29 schema:genre research_article
30 schema:inLanguage en
31 schema:isAccessibleForFree false
32 schema:isPartOf sg:journal.1092777
33 schema:name Prospective evaluation of the cardiac safety of HER2-targeted therapies in patients with HER2-positive breast cancer and compromised heart function: the SAFE-HEaRt study
34 schema:pagination 1-9
35 schema:productId N48c14e28eee04bc89a18929be17e5436
36 N4b4c758165f14b96a840217db2081d0e
37 N51f8833b125e422c9fd538572cea6860
38 N96c6dbd56e5a412a9fe5604d9821c428
39 Nbc7e6cff411b4e0da45e297e61b075f8
40 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112673022
41 https://doi.org/10.1007/s10549-019-05191-2
42 schema:sdDatePublished 2019-04-11T11:24
43 schema:sdLicense https://scigraph.springernature.com/explorer/license/
44 schema:sdPublisher Nf85d75891a5148b098c0301a9e252b46
45 schema:url https://link.springer.com/10.1007%2Fs10549-019-05191-2
46 sgo:license sg:explorer/license/
47 sgo:sdDataset articles
48 rdf:type schema:ScholarlyArticle
49 N0b0a7889e53b4483a6312cfa077fb565 rdf:first Ne6bbbfde4efe4ab099c908ebfb78f635
50 rdf:rest N55257ef2a0ed45de9ac4ed027d461762
51 N0c7c9195c304483f89155b2c65791970 rdf:first Nd95d33aa446c415eac44acf189cad6f1
52 rdf:rest N54384312589f4e0c8cc15bf1d49d503f
53 N116d14ec4b404929b175a486ec85ba76 schema:affiliation https://www.grid.ac/institutes/grid.411667.3
54 schema:familyName Warren
55 schema:givenName R.
56 rdf:type schema:Person
57 N18c8b50f02374d4ab828bdcc7b8f0be5 schema:affiliation https://www.grid.ac/institutes/grid.411667.3
58 schema:familyName Shajahan-Haq
59 schema:givenName A.
60 rdf:type schema:Person
61 N26a3941509114817901cc257df32f41f schema:affiliation https://www.grid.ac/institutes/grid.411667.3
62 schema:familyName Geng
63 schema:givenName X.
64 rdf:type schema:Person
65 N279cb06f5ac243b898ca34178dd6f7b3 schema:affiliation https://www.grid.ac/institutes/grid.411667.3
66 schema:familyName Tan
67 schema:givenName M. T.
68 rdf:type schema:Person
69 N337b271fc386442ea5346a87a9e672d4 rdf:first N3c11c5f3487147ecbe686b904175ee48
70 rdf:rest N440698d8fa3e4a8485efae4b1b50308c
71 N3538cedc73ff4d06acf043443213b127 rdf:first Nc537978984024153baa45ffa0555afd0
72 rdf:rest Nec52f5c0ad6040d19de7246c12cf1ba4
73 N3c11c5f3487147ecbe686b904175ee48 schema:affiliation https://www.grid.ac/institutes/grid.415232.3
74 schema:familyName Asch
75 schema:givenName F. M.
76 rdf:type schema:Person
77 N440698d8fa3e4a8485efae4b1b50308c rdf:first N18c8b50f02374d4ab828bdcc7b8f0be5
78 rdf:rest Nabb498312cda4560973e8b3e390b188d
79 N47559dc117ec4df29595826f879b88c2 rdf:first N73247763836b45b8825b879beda02939
80 rdf:rest N5aa1cdf1f7c8460992646e368dfb54f2
81 N47e6e46d503e4b6bb4f47d30760854f3 rdf:first N63776d88d3a04e279661d1b4baa34e51
82 rdf:rest N0b0a7889e53b4483a6312cfa077fb565
83 N48c14e28eee04bc89a18929be17e5436 schema:name readcube_id
84 schema:value 951f32d31533c18dc08e82027476972daa2e49a051a1573f30c55b2b0bd095d7
85 rdf:type schema:PropertyValue
86 N4b4c758165f14b96a840217db2081d0e schema:name dimensions_id
87 schema:value pub.1112673022
88 rdf:type schema:PropertyValue
89 N4efab5e40708489ca1925d0558812d31 rdf:first N72f71a80973740ca82b8729e76107f02
90 rdf:rest Nd9fe9d2a82ab4b11b45cb6308830ae01
91 N4f60cd1d66ac4e409dee4de99f09329b rdf:first Naadf46d8878248a48812f1ff58a9b845
92 rdf:rest N47559dc117ec4df29595826f879b88c2
93 N51f8833b125e422c9fd538572cea6860 schema:name nlm_unique_id
94 schema:value 8111104
95 rdf:type schema:PropertyValue
96 N54384312589f4e0c8cc15bf1d49d503f rdf:first Nfc0a6a25e1d244e88c304ad9e8986a15
97 rdf:rest N337b271fc386442ea5346a87a9e672d4
98 N55257ef2a0ed45de9ac4ed027d461762 rdf:first N26a3941509114817901cc257df32f41f
99 rdf:rest N5ed0d6e77c7347f0a3922f4ef53a9262
100 N5aa1cdf1f7c8460992646e368dfb54f2 rdf:first N116d14ec4b404929b175a486ec85ba76
101 rdf:rest N4efab5e40708489ca1925d0558812d31
102 N5ed0d6e77c7347f0a3922f4ef53a9262 rdf:first N691a249e81df4b258be37ac72e3af28f
103 rdf:rest Nccca0f965e964e08b85ef235146298f8
104 N5f67c4944fa1462fa96235cac3e35c15 schema:affiliation https://www.grid.ac/institutes/grid.489071.3
105 schema:familyName Hofmeyer
106 schema:givenName M.
107 rdf:type schema:Person
108 N63776d88d3a04e279661d1b4baa34e51 schema:affiliation https://www.grid.ac/institutes/grid.411667.3
109 schema:familyName Lynce
110 schema:givenName F.
111 rdf:type schema:Person
112 N674fbdf34af84969b358ebbcabe60820 schema:affiliation https://www.grid.ac/institutes/grid.411667.3
113 schema:familyName Isaacs
114 schema:givenName C.
115 rdf:type schema:Person
116 N691a249e81df4b258be37ac72e3af28f schema:affiliation https://www.grid.ac/institutes/grid.51462.34
117 schema:familyName Dang
118 schema:givenName C.
119 rdf:type schema:Person
120 N72f71a80973740ca82b8729e76107f02 schema:affiliation https://www.grid.ac/institutes/grid.411663.7
121 schema:familyName Srichai
122 schema:givenName M. B.
123 rdf:type schema:Person
124 N73247763836b45b8825b879beda02939 schema:affiliation https://www.grid.ac/institutes/grid.418152.b
125 schema:familyName Herbolsheimer
126 schema:givenName P.
127 rdf:type schema:Person
128 N7fe329eca4874924ba55e83c4a30121e rdf:first Nde0abeacf94f4bfc8be2a5f7e85a3531
129 rdf:rest N3538cedc73ff4d06acf043443213b127
130 N88a89d4e68094dfea7e8face437ea759 schema:affiliation https://www.grid.ac/institutes/grid.411667.3
131 schema:familyName Pohlmann
132 schema:givenName P. R.
133 rdf:type schema:Person
134 N96c6dbd56e5a412a9fe5604d9821c428 schema:name doi
135 schema:value 10.1007/s10549-019-05191-2
136 rdf:type schema:PropertyValue
137 Naadf46d8878248a48812f1ff58a9b845 schema:affiliation https://www.grid.ac/institutes/grid.469474.c
138 schema:familyName Nunes
139 schema:givenName R.
140 rdf:type schema:Person
141 Nabb498312cda4560973e8b3e390b188d rdf:first N279cb06f5ac243b898ca34178dd6f7b3
142 rdf:rest Nd4a01a85be6d46e98f7c1e6880787ade
143 Nbc7e6cff411b4e0da45e297e61b075f8 schema:name pubmed_id
144 schema:value 30852761
145 rdf:type schema:PropertyValue
146 Nc537978984024153baa45ffa0555afd0 schema:affiliation https://www.grid.ac/institutes/grid.415235.4
147 schema:familyName Gallagher
148 schema:givenName C.
149 rdf:type schema:Person
150 Nccca0f965e964e08b85ef235146298f8 rdf:first Nf691228294684fa4a3343b66d8f067e2
151 rdf:rest N7fe329eca4874924ba55e83c4a30121e
152 Nd4a01a85be6d46e98f7c1e6880787ade rdf:first N674fbdf34af84969b358ebbcabe60820
153 rdf:rest Nee60d5df34b14a5e87b2e1f496190a19
154 Nd95d33aa446c415eac44acf189cad6f1 schema:affiliation https://www.grid.ac/institutes/grid.415232.3
155 schema:familyName Cunningham
156 schema:givenName A.
157 rdf:type schema:Person
158 Nd9fe9d2a82ab4b11b45cb6308830ae01 rdf:first N5f67c4944fa1462fa96235cac3e35c15
159 rdf:rest N0c7c9195c304483f89155b2c65791970
160 Nde0abeacf94f4bfc8be2a5f7e85a3531 schema:affiliation https://www.grid.ac/institutes/grid.469474.c
161 schema:familyName Smith
162 schema:givenName K. L.
163 rdf:type schema:Person
164 Ne6bbbfde4efe4ab099c908ebfb78f635 schema:affiliation https://www.grid.ac/institutes/grid.489071.3
165 schema:familyName Barac
166 schema:givenName A.
167 rdf:type schema:Person
168 Nec52f5c0ad6040d19de7246c12cf1ba4 rdf:first N88a89d4e68094dfea7e8face437ea759
169 rdf:rest N4f60cd1d66ac4e409dee4de99f09329b
170 Nee60d5df34b14a5e87b2e1f496190a19 rdf:first Nfd151cd6aa594a76902c6ad4989379fa
171 rdf:rest rdf:nil
172 Nf691228294684fa4a3343b66d8f067e2 schema:affiliation https://www.grid.ac/institutes/grid.51462.34
173 schema:familyName Yu
174 schema:givenName A. F.
175 rdf:type schema:Person
176 Nf85d75891a5148b098c0301a9e252b46 schema:name Springer Nature - SN SciGraph project
177 rdf:type schema:Organization
178 Nfc0a6a25e1d244e88c304ad9e8986a15 schema:affiliation https://www.grid.ac/institutes/grid.415232.3
179 schema:familyName Timothee
180 schema:givenName P.
181 rdf:type schema:Person
182 Nfd151cd6aa594a76902c6ad4989379fa schema:affiliation https://www.grid.ac/institutes/grid.411667.3
183 schema:familyName Swain
184 schema:givenName S. M.
185 rdf:type schema:Person
186 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
187 schema:name Medical and Health Sciences
188 rdf:type schema:DefinedTerm
189 anzsrc-for:1102 schema:inDefinedTermSet anzsrc-for:
190 schema:name Cardiorespiratory Medicine and Haematology
191 rdf:type schema:DefinedTerm
192 sg:grant.2438858 http://pending.schema.org/fundedItem sg:pub.10.1007/s10549-019-05191-2
193 rdf:type schema:MonetaryGrant
194 sg:journal.1092777 schema:issn 0167-6806
195 1573-7217
196 schema:name Breast Cancer Research and Treatment
197 rdf:type schema:Periodical
198 https://doi.org/10.1016/j.echo.2009.05.020 schema:sameAs https://app.dimensions.ai/details/publication/pub.1039554114
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/j.echo.2014.10.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035112289
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/j.echo.2017.11.018 schema:sameAs https://app.dimensions.ai/details/publication/pub.1100778508
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/j.jchf.2017.08.024 schema:sameAs https://app.dimensions.ai/details/publication/pub.1093117030
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1056/nejm200103153441101 schema:sameAs https://app.dimensions.ai/details/publication/pub.1031768583
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1056/nejmoa052122 schema:sameAs https://app.dimensions.ai/details/publication/pub.1035589584
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1056/nejmoa052306 schema:sameAs https://app.dimensions.ai/details/publication/pub.1014794593
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1056/nejmoa0910383 schema:sameAs https://app.dimensions.ai/details/publication/pub.1028192490
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1056/nejmoa1209124 schema:sameAs https://app.dimensions.ai/details/publication/pub.1042743567
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1056/nejmoa1413513 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043562849
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1093/annonc/mdt182 schema:sameAs https://app.dimensions.ai/details/publication/pub.1049729330
219 rdf:type schema:CreativeWork
220 https://doi.org/10.1093/annonc/mdx773 schema:sameAs https://app.dimensions.ai/details/publication/pub.1099838694
221 rdf:type schema:CreativeWork
222 https://doi.org/10.1093/eurheartj/ehw022 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047825539
223 rdf:type schema:CreativeWork
224 https://doi.org/10.1200/jco.2005.02.4091 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024439769
225 rdf:type schema:CreativeWork
226 https://doi.org/10.1200/jco.2005.13.300 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036436122
227 rdf:type schema:CreativeWork
228 https://doi.org/10.1200/jco.2007.13.5467 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011604292
229 rdf:type schema:CreativeWork
230 https://doi.org/10.1200/jco.2011.40.0010 schema:sameAs https://app.dimensions.ai/details/publication/pub.1007962595
231 rdf:type schema:CreativeWork
232 https://doi.org/10.1200/jco.2016.68.7830 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079360339
233 rdf:type schema:CreativeWork
234 https://doi.org/10.1200/jco.2016.70.5400 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079363808
235 rdf:type schema:CreativeWork
236 https://doi.org/10.1634/theoncologist.2015-0125 schema:sameAs https://app.dimensions.ai/details/publication/pub.1068164525
237 rdf:type schema:CreativeWork
238 https://doi.org/10.1634/theoncologist.2016-0412 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084355312
239 rdf:type schema:CreativeWork
240 https://doi.org/10.3109/07357907.2014.922570 schema:sameAs https://app.dimensions.ai/details/publication/pub.1045073061
241 rdf:type schema:CreativeWork
242 https://www.grid.ac/institutes/grid.411663.7 schema:alternateName MedStar Georgetown University Hospital
243 schema:name Department of Cardiology, MedStar Georgetown University Hospital, Washington, DC, USA
244 MedStar Heart & Vascular Institute, Washington, DC, USA
245 rdf:type schema:Organization
246 https://www.grid.ac/institutes/grid.411667.3 schema:alternateName Georgetown University Medical Center
247 schema:name Department of Biostatistics, Bioinformatics & Biomathematics, Georgetown University Medical Center, Washington, DC, USA
248 Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, 20057-1400, Washington, DC, USA
249 rdf:type schema:Organization
250 https://www.grid.ac/institutes/grid.415232.3 schema:alternateName MedStar Health
251 schema:name MedStar Health Research Institute, Hyattsville, MD, USA
252 MedStar Heart & Vascular Institute, Washington, DC, USA
253 rdf:type schema:Organization
254 https://www.grid.ac/institutes/grid.415235.4 schema:alternateName MedStar Washington Hospital Center
255 schema:name Washington Cancer Institute, MedStar Washington Hospital Center, Washington, DC, USA
256 rdf:type schema:Organization
257 https://www.grid.ac/institutes/grid.418152.b schema:alternateName AstraZeneca (United States)
258 schema:name AstraZeneca, Gaithersburg, MD, USA
259 rdf:type schema:Organization
260 https://www.grid.ac/institutes/grid.469474.c schema:alternateName Johns Hopkins Medicine
261 schema:name The Johns Hopkins University School of Medicine, Baltimore, MD, USA
262 The Johns Hopkins University Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD, USA
263 rdf:type schema:Organization
264 https://www.grid.ac/institutes/grid.489071.3 schema:alternateName MedStar Heart & Vascular Institute
265 schema:name Georgetown Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, 4000 Reservoir Road NW, 120 Building D, 20057-1400, Washington, DC, USA
266 MedStar Heart & Vascular Institute, Washington, DC, USA
267 rdf:type schema:Organization
268 https://www.grid.ac/institutes/grid.51462.34 schema:alternateName Memorial Sloan Kettering Cancer Center
269 schema:name Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA
270 Department of Medicine, Weill Cornell Medical College, New York, NY, USA
271 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...